“`html
Researchers Discover “Key” to Brain Aging
Researchers have identified a critical mechanism driving brain aging,possibly opening new avenues for preventing and treating age-related cognitive decline. A study published in Nature Aging on january 19, 2026, details the role of a protein called ‘neuronal growth differentiation factor 9‘ (NGDF9) in maintaining synaptic plasticity – the brain’s ability to form new connections – and how its decline contributes to cognitive impairment. [https://www.nature.com/articles/s41514-026-00100-x]
The Role of NGDF9 in Brain Health
As we age, the brain’s ability to form new connections weakens, leading to memory loss and other cognitive deficits. This decline is largely attributed to the loss of synaptic plasticity. The research team, led by Dr. Anya Sharma at the University of california, San Francisco, discovered that NGDF9 plays a crucial role in preserving this plasticity.
“We found that NGDF9 levels naturally decrease with age,and this reduction directly correlates with a decline in synaptic function,” explains Dr. Sharma. “By restoring NGDF9 levels in aged mice, we were able to significantly improve their cognitive performance, essentially reversing some of the effects of aging.” [https://www.ucsf.edu/news/2026/01/brain-aging-ngdf9-discovery]
How NGDF9 Impacts Synaptic Plasticity
NGDF9 appears to work by regulating the expression of genes involved in synaptic formation and maintenance. Specifically, it promotes the production of proteins essential for strengthening connections between neurons. The study showed that reduced NGDF9 levels lead to a decrease in the density of dendritic spines – the small protrusions on neurons that receive signals from other neurons – and a reduction in the efficiency of synaptic transmission.
Restoring NGDF9: Potential Therapeutic Strategies
The researchers explored several methods for boosting NGDF9 levels in the brain. Gene therapy, delivering the NGDF9 gene directly to neurons, showed the most promising results in animal models. However, Dr. Sharma’s team is also investigating the potential of small molecule drugs that can stimulate NGDF9 production.
“Developing a drug that can safely and effectively increase NGDF9 levels could be a game-changer in the fight against age-related cognitive decline,” says Dr. David Lee, a neuroscientist at the National Institutes of Health, who was not involved in the study.[https://www.nih.gov/news-events/news-releases/ngdf9-discovery-holds-promise-treating-age-related-cognitive-decline]
Future Research and Clinical Trials
While the findings are encouraging, further research is needed to determine the safety and efficacy of NGDF9-based
Keep reading